Peterson LM, Kurland BF, Yan F, Novakova-Jiresova A, et al. (18)F-Fluoroestradiol ((18)F-FES)-PET imaging in a Phase II trial of vorinostat
to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer. J Nucl Med 2020 Jun 26. pii: jnumed.120.244459. doi: 10.2967/jnumed.120.244459.
PMID: 32591490